Back to top

Tale of the Tape

Acorda Therapeutics, Inc. (ACOR - Analyst Report) was a big mover last session, as the company saw its shares rise by roughly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.  This continues the recent uptrend for the company as the stock is now up almost 37% in the past one-month time frame.

This biotechnology company has seen one positive estimate revision and five negative estimate revisions over the last 30 days and its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
    
Acorda Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include Alkermes plc (ALKS - Analyst Report), Alexion Pharmaceuticals, Inc. (ALXN - Analyst Report) and Gilead Sciences Inc. (GILD - Analyst Report). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Please login to Zacks.com or register to post a comment.